Marathon Trading Investment Management’s AbbVie ABBV Stock Holding History

Marathon Trading Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,500	Closed	-$314K	–	273
2025 Q1	$314K	Buy	1,500 +1,100	+275%	+$214K	0.04%	182
2024 Q4	$71.1K	Buy	400 +200	+100%	+$36.8K	﹤0.01%	257
2024 Q3	$39.5K	Buy	+200	New	+$37.3K	﹤0.01%	244
2023 Q3	–	Sell	-300	Closed	-$40.4K	–	333
2023 Q2	$40.4K	Buy	+300	New	+$44K	﹤0.01%	229
2022 Q3	–	Sell	-2,300	Closed	-$352K	–	281
2022 Q2	$352K	Sell	2,300 -100	-4%	-$15.3K	0.04%	184
2022 Q1	$389K	Buy	+2,400	New	+$349K	0.03%	192
2021 Q1	–	Sell	-18,000	Closed	-$1.93M	–	391
2020 Q4	$1.93M	Buy	+18,000	New	+$1.73M	0.1%	105
2019 Q3	–	Sell	-21,700	Closed	-$1.58M	–	187
2019 Q2	$1.58M	Buy	+21,700	New	+$1.71M	0.14%	100

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Marathon Trading Investment Management's ABBV Position: Q3 2023 in Review

Marathon Trading Investment Management sold out of AbbVie (ABBV) in Q3 2023, closing a stake of 1,000 shares — an estimated $147K sold.

Marathon Trading Investment Management first reported a position in ABBV in Q2 2019 and held it in 8 quarters. The position peaked at $1.18M in Q2 2019. 3,110 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Marathon Trading Investment Management reported no remaining AbbVie position as of Q3 2023 after selling out during the quarter.
Marathon Trading Investment Management sold 1,000 AbbVie shares in Q3 2023, an estimated $147K.
Marathon Trading Investment Management first reported a position in AbbVie in Q2 2019 and held it in 8 quarters.
Marathon Trading Investment Management's AbbVie position peaked at $1.18M in Q2 2019.
3,110 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Marathon Trading Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.